Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-01 | Mary Ann Cloyd—64, Director Nominee. Ms. Cloyd was a senior Partner with PricewaterhouseCoopers LLP, until her retirement in June 2015. Ms. Cloyd is a retired Certified Public Accountant. Between 2004 and 2013, she served on both PwC's Global and U.S. Boards of Partners and Principals. She has been on the boards of directors of Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company, since February 2016 and NCMIC Group, Inc., a mutual insurance and financial services company, since April 2018. |
| 2020-03-19 | Mary Ann Cloyd Former Senior Partner PricewaterhouseCoopers LLP Audit (Chair) and Governance |
| 2021-03-23 | Mary Ann Cloyd, Director Since: 2019, Age: 66, Former Senior Partner, PricewaterhouseCoopers LLP. Committees: Audit (Chair) and Governance (Chair). Compensation: $294,795. |
| 2022-04-22 | Mary Ann Cloyd, Director Since: 2019, Age: 67, Retired Senior Partner, PricewaterhouseCoopers LLP ... Committees: Audit (Chair), Governance ... Director Compensation: Fees Earned or Paid in Cash $125,000, Stock Awards $124,933, Total $249,993. |
| 2023-03-24 | Mary Ann Cloyd 2019 68 Retired Senior Partner, PricewaterhouseCoopers LLP Audit (Chair) Governance Fees Earned or Paid in Cash 120,000 Stock Awards 149,118 Total 269,118 |
| 2024-04-26 | Mary Ann Cloyd Director Since: 2019 Age: 69 Retired Senior Partner, PricewaterhouseCoopers LLP Audit (Chair) Governance Fees Earned or Paid in Cash: 120,000 Stock Awards: 150,206 Total: 270,206 |
Data sourced from SEC filings. Last updated: 2026-03-05